Role of interendothelial adhesion molecules in the control of vascular functions

Vascular Pharmacology

Volumn 39, Issue 4-5, 2002, Pages 239-246

  Aurrand Lions, Michel ^a   Johnson Léger, Caroline ^a   Imhof, Beat A ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

CD99; JAM; Leukocyte transmigration; PECAM 1

Indexed keywords

ANTIINFLAMMATORY AGENT; CELL ADHESION MOLECULE; CORTICOSTEROID; LIGAND; NITRIC OXIDE; XANTHINE DERIVATIVE;

BLOOD VESSEL PERMEABILITY; CELL INTERACTION; CYTOSKELETON; ENDOTHELIUM; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; LEUKOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL MEMBRANE PERMEABILITY; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; TIGHT JUNCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION MOLECULES; CELL MEMBRANE PERMEABILITY; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM, VASCULAR; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS;

EID: 0042845699     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(03)00012-0     Document Type: Review

References (87)

1. Albelda S.M., Oliver P.D., Romer L.H., Buck C.A. EndoCAM: a novel endothelial cell-cell adhesion molecule. J. Cell Biol. 110:1990;1227-1237.
2. Alberti I., Bernard G., Rouquette-Jazdanian A.K., Pelassy C., Pourtein M., Aussel C., Bernard A. CD99 isoform expression dictates T-cell functional outcomes. FASEB J. 4:2002;4.
3. Allport J.R., Ding H., Collins T., Gerritsen M.E., Luscinskas F.W. Endothelial-dependent mechanisms regulate leukocyte transmigration: a process involving the proteasome and disruption of the vascular endothelial-cadherin complex at endothelial cell-to-cell junctions. J. Exp. Med. 186:1997;517-527.
4. Allport J.R., Muller W.A., Luscinskas F.W. Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow. J. Cell Biol. 148:2000;203-216.
5. Alon R., Feigelson S. From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin. Immunol. 14:2002;93-104.
6. Arrate M.P., Rodriguez J.M., Tran T.M., Brock T.A., Cunningham S.A. Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J. Biol. Chem. 276:2001;45826-45832.
7. Aurrand-Lions M.A., Duncan L., Du Pasquier L., Imhof B.A. Cloning of JAM-2 and JAM-3: an emerging junctional adhesion molecular family? Curr. Top. Microbiol. Immunol. 251:2000;91-98.
8. Aurrand-Lions M., Johnson-Leger C., Wong C., Du Pasquier L., Imhof B.A. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood. 98:2001;3699-3707.
9. Aurrand-Lions M.A., Duncan L., Ballestrem C., Imhof B.A. JAM-2, a novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J. Biol. Chem. 276:2001;2733-2741.
10. Ayalon O., Sabanai H., Lampugnani M.G., Dejana E., Geiger B. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J. Cell Biol. 126:1994;247-258.
11. Bach T.L., Barsigian C., Yaen C.H., Martinez J. Endothelial cell VE-cadherin functions as a receptor for the beta 15-42 sequence of fibrin. J. Biol. Chem. 273:1998;30719-30728.
12. Bazzoni G., Martinez-Estrada O.M., Mueller F., Nelboeck P., Schmid G., Bartfai T., Dejana E., Brockhaus M. Homophilic interaction of junctional adhesion molecule. J. Biol. Chem. 275(40):2000;30970-30976.
13. Bazzoni G., Martinez-Estrada O.M., Orsenigo F., Cordenonsi M., Citi S., Dejana E. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J. Biol. Chem. 275:2000;20520-20526.
14. Ben-Ze'ev A., Shtutman M., Zhurinsky J. The integration of cell adhesion with gene expression: the role of beta-catenin. Exp. Cell Res. 261:2000;75-82.
15. Bernard G., Zoccola D., Deckert M., Breittmayer J.P., Aussel C., Bernard A. The E2 molecule (CD99) specifically triggers homotypic aggregation of CD4+ CD8+ thymocytes. J. Immunol. 154:1995;26-32.
16. Bernard G., Raimondi V., Alberti I., Pourtein M., Widjenes J., Ticchioni M., Bernard A. CD99 (E2) up-regulates alpha4beta1-dependent T cell adhesion to inflamed vascular endothelium under flow conditions. Eur. J. Immunol. 30:2000;3061-3065.
17. Bird I.N., Taylor V., Newton J.P., Spragg J.H., Simmons D.L., Salmon M., Buckley C.D. Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration. J. Cell Sci. 112(Pt 12):1999;1989-1997.
18. Breviario F., Caveda L., Corada M., Martin-Padura I., Navarro P., Golay J., Introna M., Gulino D., Lampugnani M.G., Dejana E. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler. Thromb. Vasc. Biol. 15:1995;1229-1239.
19. Buckley C.D., Doyonnas R., Newton J.P., Blystone S.D., Brown E.J., Watt S.M., Simmons D.L. Identification of alpha v beta 3 as a heterotypic ligand for CD31/PECAM-1. J. Cell Sci. 109:1996;437-445.
20. Burns A.R., Walker D.C., Brown E.S., Thurmon L.T., Bowden R.A., Keese C.R., Simon S.I., Entman M.L., Smith C.W. Neutrophil transendothelial migration is independent of tight junctions and occurs preferentially at tricellular corners. J. Immunol. 159:1997;2893-2903.
21. Burns A.R., Bowden R.A., MacDonell S.D., Walker D.C., Odebunmi T.O., Donnachie E.M., Simon S.I., Entman M.L., Smith C.W. Analysis of tight junctions during neutrophil transendothelial migration. J. Cell Sci. 113:2000;45-57.
22. Bussolino F., Serini G., Mitola S., Bazzoni G., Dejana E. Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells. EMBO Rep. 2:2001;763-767.
23. Butcher E.C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 67:1991;1033-1036.
24. Carmeliet P., Lampugnani M.G., Moons L., Breviario F., Compernolle V., Bono F., Balconi G., Spagnuolo R., Oostuyse B., Dewerchin M., Zanetti A., Angellilo A., Mattot V., Nuyens D., Lutgens E., Clotman F., de Ruiter M.C., Gittenberger-de Groot A., Poelmann R., Lupu F., Herbert J.M., Collen D., Dejana E. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 98:1999;147-157.
25. Corada M., Mariotti M., Thurston G., Smith K., Kunkel R., Brockhaus M., Lampugnani M.G., Martin-Padura I., Stoppacciaro A., Ruco L., McDonald D.M., Ward P.A., Dejana E. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc. Natl. Acad. Sci. U. S. A. 96:1999;9815-9820.
26. Corada M., Liao F., Lindgren M., Lampugnani M.G., Breviario F., Frank R., Muller W.A., Hicklin D.J., Bohlen P., Dejana E. Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood. 97:2001;1679-1684.
27. Corada M., Zanetta L., Orsenigo F., Breviario F., Lampugnani M.G., Bernasconi S., Liao F., Hicklin D.J., Bohlen P., Dejana E. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood. 100:2002;905-911.
28. Cunningham S.A., Arrate M.P., Rodriguez J.M., Bjercke R.J., Vanderslice P., Morris A.P., Brock T.A. A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. J. Biol. Chem. 275:2000;34750-34756.
29. Cunningham S.A., Rodriguez J.M., Arrate M.P., Tran T.M., Brock T.A. JAM2 interacts with alpha4beta1. Facilitation by JAM3. J. Biol. Chem. 277:2002;27589-27592.
30. Dejana E., Lampugnani M.G., Martinez-Estrada O., Bazzoni G. The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability. Int. J. Dev. Biol. 44:2000;743-748.
31. Duncan G.S., Andrew D.P., Takimoto H., Kaufman S.A., Yoshida H., Spellberg J., Luis de la Pompa J., Elia A., Wakeham A., Karan-Tamir B., Muller W.A., Senaldi G., Zukowski M.M., Mak T.W. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J. Immunol. 162:1999;3022-3030.
32. Ebnet K., Schulz C.U., Meyer Zu Brickwedde M.K., Pendl G.G., Vestweber D. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J. Biol. Chem. 275:2000;27979-27988.
33. Ebnet K., Suzuki A., Horikoshi Y., Hirose T., Meyer Zu Brickwedde M.K., Ohno S., Vestweber D. The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). EMBO J. 20:2001;3738-3748.
34. Esser S., Lampugnani M.G., Corada M., Dejana E., Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J. Cell Sci. 111:1998;1853-1865.
35. Faveeuw C., Preece G., Ager A. Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood. 98:2001;688-695.
36. 2-terminal portions of the fibrin beta chains. Biochemistry. 41:2002;4107-4116.
37. Gotsch U., Borges E., Bosse R., Boggemeyer E., Simon M., Mossmann H., Vestweber D. VE-cadherin antibody accelerates neutrophil recruitment in vivo. J. Cell Sci. 110:1997;583-588.
38. Hahn J.H., Kim M.K., Choi E.Y., Kim S.H., Sohn H.W., Ham D.I., Chung D.H., Kim T.J., Lee W.J., Park C.K., Ree H.J., Park S.H. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J. Immunol. 159:1997;2250-2258.
39. Hirata K., Ishida T., Penta K., Rezaee M., Yang E., Wohlgemuth J., Quertermous T. Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells. J. Biol. Chem. 276:2001;16223-16231.
40. Hordijk P.L., Anthony E., Mul F.P., Rientsma R., Oomen L.C., Roos D. Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J. Cell Sci. 112(Pt 12):1999;1915-1923.
41. Ilan N., Cheung L., Pinter E., Madri J.A. Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J. Biol. Chem. 275:2000;21435-21443.
42. Johnson-Leger C., Aurrand-Lions M., Imhof B.A. The parting of the endothelium: miracle, or simply a junctional affair? J. Cell Sci. 113:2000;921-933.
43. Johnson-Leger C.A., Aurrand-Lions M., Beltraminelli N., Fasel N., Imhof B.A. Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. Blood. 100:2002;2479-2486.
44. Kostrewa D., Brockhaus M., D'Arcy A., Dale G.E., Nelboeck P., Schmid G., Mueller F., Bazzoni G., Dejana E., Bartfai T., Winkler F.K., Hennig M. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J. 20:2001;4391-4398.
45. Lampugnani M.G., Resnati M., Raiteri M., Pigott R., Pisacane A., Houen G., Ruco L.P., Dejana E. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J. Cell Biol. 118:1992;1511-1522.
46. Lampugnani M.G., Corada M., Caveda L., Breviario F., Ayalon O., Geiger B., Dejana E. The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J. Cell Biol. 129:1995;203-217.
47. Lampugnani M.G., Corada M., Andriopoulou P., Esser S., Risau W., Dejana E. Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J. Cell Sci. 110:1997;2065-2077.
48. Liang T.W., DeMarco R.A., Mrsny R.J., Gurney A., Gray A., Hooley J., Aaron H.L., Huang A., Klassen T., Tumas D.B., Fong S. Characterization of huJAM: evidence for involvement in cell-cell contact and tight junction regulation. Am. J. Physiol., Cell Physiol. 279:2000;C1733-C1743.
49. Liang T.W., Chiu H.H., Gurney A., Sidle A., Tumas D.B., Schow P., Foster J., Klassen T., Dennis K., DeMarco R.A., Pham T., Frantz G., Fong S. Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3. J. Immunol. 168:2002;1618-1626.
50. Liao F., Huynh H.K., Eiroa A., Greene T., Polizzi E., Muller W.A. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J. Exp. Med. 182:1995;1337-1343.
51. Liao F., Ali J., Greene T., Muller W.A. Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J. Exp. Med. 185:1997;1349-1357.
52. Litwin M., Clark K., Noack L., Furze J., Berndt M., Albelda S., Vadas M., Gamble J. Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31). J. Cell Biol. 139:1997;219-228.
53. Liu Y., Nusrat A., Schnell F.J., Reaves T.A., Walsh S., Pochet M., Parkos C.A. Human junction adhesion molecule regulates tight junction resealing in epithelia. J. Cell Sci. 113:2000;2363-2374.
54. Lu T.T., Barreuther M., Davis S., Madri J.A. Platelet endothelial cell adhesion molecule-1 is phosphorylatable by c-Src, binds Src-Src homology 2 domain, and exhibits immunoreceptor tyrosine-based activation motif-like properties. J. Biol. Chem. 272:1997;14442-14446.
55. Luscinskas F.W., Ma S., Nusrat A., Parkos C.A., Shaw S.K. Leukocyte transendothelial migration: a junctional affair. Semin. Immunol. 14:2002;105-113.
56. Malergue F., Galland F., Martin F., Mansuelle P., Aurrand-Lions M., Naquet P. A novel immunoglobulin superfamily junctional molecule expressed by antigen presenting cells, endothelial cells and platelets. Mol. Immunol. 35:1998;1111-1119.
57. Martinez-Estrada O.M., Villa A., Breviario F., Orsenigo F., Dejana E., Bazzoni G. Association of junctional adhesion molecule with calcium/calmodulin- dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells. J. Biol. Chem. 276:2001;9291-9296.
58. Martin-Padura I., Lostaglio S., Schneemann M., Williams L., Romano M., Fruscella P., Panzeri C., Stoppacciaro A., Ruco L., Villa A., Simmons D., Dejana E. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 142:1998;117-127.
59. Moll T., Dejana E., Vestweber D. In vitro degradation of endothelial catenins by a neutrophil protease. J. Cell Biol. 140:1998;403-407.
60. Morita K., Sasaki H., Furuse M., Tsukita S. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147:1999;185-194.
61. Muller W.A. Migration of leukocytes across endothelial junctions: some concepts and controversies. Microcirculation. 8:2001;181-193.
62. Muller W.A., Weigl S.A., Deng X., Phillips D.M. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178:1993;449-460.
63. Nasdala I., Wolburg-Buchholz K., Wolburg H., Kuhn A., Ebnet K., Brachtendorf G., Samulowitz U., Kuster B., Engelhardt B., Vestweber D., Butz S. A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J. Biol. Chem. 277:2002;16294-16303.
64. Nawroth R., Poell G., Ranft A., Kloep S., Samulowitz U., Fachinger G., Golding M., Shima D.T., Deutsch U., Vestweber D. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J. 21:2002;4885-4895.
65. Newman P.J., Berndt M.C., Gorski J., White G.d., Lyman S., Paddock C., Muller W.A. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science. 247:1990;1219-1222.
66. Newman D.K., Hamilton C., Newman P.J. Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood. 97:2001;2351-2357.
67. Ostermann G., Weber K.S., Zernecke A., Schroder A., Weber C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat. Immunol. 3:2002;151-158.
68. Ozaki H., Ishii K., Horiuchi H., Arai H., Kawamoto T., Okawa K., Iwamatsu A., Kita T. Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J. Immunol. 163:1999;553-557.
69. Palmeri D., van Zante A., Huang C.C., Hemmerich S., Rosen S.D. Vascular endothelial junction-associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J. Biol. Chem. 275:2000;19139-19145.
70. Pettersen R.D., Bernard G., Olafsen M.K., Pourtein M., Lie S.O. CD99 signals caspase-independent T cell death. J. Immunol. 166:2001;4931-4942.
71. Piali L., Hammel P., Uherek C., Bachmann F., Gisler R.H., Dunon D., Imhof B.A. CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J. Cell Biol. 130:1995;451-460.
72. Sagawa K., Kimura T., Swieter M., Siraganian R.P. The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31). J. Biol. Chem. 272:1997;31086-31091.
73. Santoso S., Sachs U.J., Kroll H., Linder M., Ruf A., Preissner K.T., Chavakis T. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J. Exp. Med. 196:2002;679-691.
74. Schenkel A.R., Mamdouh Z., Chen X., Liebman R.M., Muller W.A. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3:2002;143-150.
75. Shaw S.K., Bamba P.S., Perkins B.N., Luscinskas F.W. Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J. Immunol. 167:2001;2323-2330.
76. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
77. Steinberg M.S., McNutt P.M. Cadherins and their connections: adhesion junctions have broader functions. Curr. Opin. Cell Biol. 11:1999;554-560.
78. Sun J., Williams J., Yan H.C., Amin K.M., Albelda S.M., DeLisser H.M. Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J. Biol. Chem. 271:1996;18561-18570.
79. Thompson R.D., Noble K.E., Larbi K.Y., Dewar A., Duncan G.S., Mak T.W., Nourshargh S. Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. Blood. 97:2001;1854-1860.
80. Tsukita S., Furuse M., Itoh M. Multifunctional strands in tight junctions. Nat. Rev., Mol. Cell Biol. 2:2001;285-293.
81. Vestweber D. Molecular mechanisms that control endothelial cell contacts. J. Pathol. 190:2000;281-291.
82. Vestweber D. Regulation of endothelial cell contacts during leukocyte extravasation. Curr. Opin. Cell. Biol. 14:2002;587.
83. Vestweber D., Blanks J.E. Mechanisms that regulate the function of the selectins and their ligands. Physiol. Rev. 79:1999;181-213.
84. von Andrian U.H., Mackay C.R. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 343:2000;1020-1034.
85. Wolburg H., Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vasc. Pharmacol. 38:2002;323-337.
86. Wong C.W., Wiedle G., Ballestrem C., Wehrle-Haller B., Etteldorf S., Bruckner M., Engelhardt B., Gisler R.H., Imhof B.A. PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in cis. Mol. Biol. Cell. 11:2000;3109-3121.
87. Zhao T., Newman P.J. Integrin activation by regulated dimerization and oligomerization of platelet endothelial cell adhesion molecule (PECAM)-1 from within the cell. J. Cell Biol. 152:2001;65-73.